Embassy Event Services (part of the Embasssy Freight Group)
Embassy Event Services ( as part of the Embassy Freight Group) are 100% committed to supporting all UK based Lifescience companies ( and BioPartner UK) in making all event logistics as simple, reliable , and cost effective as possible, with this in mind, we offer all BioPartner UK members personalised event logistic services and discounted freight costs. We are proud to be part of the BioPartner UK family and will continue to support UK Life science and the BioPartner UK membership on all their event logistic requirements – from shipping to stand building to customs formalities – nothing is left to chance!
We make it our business to deliver on our commitments with honesty and responsibility - we have an established event team providing a personal, dedicated service backed up by an advanced and flexible I.T. infrastructure. For the diverse requirements of our clients - our philosophy remains the same: to understand the clients needs, to accept the challenge given, and to deliver a first class service to all clients For further information contact – firstname.lastname@example.org
Epidarex Capital invests in early-stage, high growth life science and health technology companies in under-ventured markets within the UK and US. Epidarex funds the commercialization of ground-breaking research and new technologies to address large and unmet needs in today’s healthcare market.
ERA is able to contribute at any stage of product development, from discovery, through process development, non-clinical and clinical aspects, to regulatory approval and beyond. One of our recognised specialities is the design of a regulatory strategy, to cover part or all of the development process. Thus, our services include the following: Regulatory due diligence exercises for in- or out-licensing, interactions with regulatory agencies, such as pre-IND, pre-BLA and scientific advice procedures, clinical trial applications, marketing authorisation applications, including eCTD submissions, post-approval amendments or variations, advice on process development, including validation, input on characterisation and control, consulting on non-clinical and clinical strategy, facility inspections and support for establishment licensing.